Study in Post-menopausal Women With Hormone Receptor Positive, HER2-negative Advanced Breast Cancer
Clinical trial NCT03176238 · COMPLETED
Trial details
- NCT number
- NCT03176238
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-03-29
- Primary completion
- 2019-01-29
- Enrollment
- 235
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.